Detect and protect against antibiotic resistance : CDC’s initiative to outsmart this threat
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All

Detect and protect against antibiotic resistance : CDC’s initiative to outsmart this threat

Filetype[PDF-688.44 KB]

  • English

  • Details:

    • Description:
      It’s been called public health’s ticking time bomb. Antibiotic resistance—when bacteria don’t respond to the drugs designed to kill them—threatens to return us to the time when simple infections were often fatal. Today, antibiotic resistance annually causes more than 2 million illnesses and 23,000 deaths in the United States. Tomorrow, if it continues on its current course, could be even worse: • A simple cut of the finger could lead to a life threatening infection. • Common surgical procedures, such as hip and knee replacements, would be far riskier because of the danger of infection. • Dialysis patients could develop untreatable bloodstream infections. • Life-saving treatments that suppress immune systems, such as chemotherapy and organ transplants, could potentially cause more harm than good. We need to outsmart antibiotic resistance—now. The Detect and Protect Against Antibiotic Resistance Initiative (known as the AR Initiative) gives us a good head start. The 2015 President’s Budget requests $30 million annual funding level for 5 years for the AR Initiative—part of a broader CDC strategy to target investment to achieve measureable results in four core areas: • Detect and track patterns of antibiotic resistance. • Respond to outbreaks involving antibiotic-resistant bacteria. • Prevent infections from occurring and resistant bacteria from spreading. • Discover new antibiotics and new diagnostic tests for resistant bacteria. CS246167
    • Document Type:
    • Main Document Checksum:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at